Role of nuclear cardiology for guiding device therapy in patients with heart failure

doi:10.13105/wjma.v2.i1.1

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 1

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7169)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

485

WORD

371

HTML

3547

Figures (1-4)

170

Tables (1-2)

190

Sum=4763

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1140

Download

1266

Sum=2406

Feb 26, 2014 (publication date) through Jul 3, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Meta-Analysis

ISSN

2308-3840

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Meta-Anal. Feb 26, 2014; 2(1): 1-16
Published online Feb 26, 2014. doi: 10.13105/wjma.v2.i1.1

Full Size Figure Download Figure

Figure 1 Metaiodobenzylguanidine imaging protocol including planar and single-photon emission computed tomography images obtained 15 to 30 min (early) and 3 to 4 h (late) after intravenous injection of 111 to 370 MBq of ¹²³I-metaiodobenzylguanidine. MIBG: Metaiodobenzylguanidine.

Citation: Petretta M, Petretta A, Pellegrino T, Nappi C, Cantoni V, Cuocolo A. Role of nuclear cardiology for guiding device therapy in patients with heart failure. World J Meta-Anal 2014; 2(1): 1-16
URL: https://www.wjgnet.com/2308-3840/full/v2/i1/1.htm
DOI: https://dx.doi.org/10.13105/wjma.v2.i1.1